Zobrazeno 1 - 10
of 16
pro vyhledávání: '"S Virciglio"'
Autor:
V Camartini, F Orso, A Herbst, F Verga, C Salucci, S Virciglio, S Baldasseroni, A Ungar, G D‘errico
Publikováno v:
European Heart Journal Supplements. 25:D173-D173
Background Intermittent infusions of Levosimendan (L) have been shown to reduce hospitalizations and improve quality of life in patients with advanced heart failure (HF). "Real–world" experience is currently insufficient, particularly in older pati
Autor:
G D‘Errico, A Herbst, F Orso, S Baldasseroni, F Fattirolli, S Virciglio, V Camartini, M Di Bari, N Marchionni, A Ungar, C Salucci, F Verga
Publikováno v:
European Heart Journal Supplements. 24
Background After the lockdown imposed by the COVID19 pandemic, physicians had to limite ambulatory visits to exceptional cases to reduce interpersonal contact. We structured a telephone follow–up developing a standardized 23 item questionnaire to a
Autor:
C Salucci, E Girardi, F Orso, A Herbst, M Migliorini, C Ghiara, S Virciglio, V Camartini, S Tognelli, G Fortini, M Di Bari, S Baldasseroni, A Ungar, N Marchionni, F Fattirolli
Publikováno v:
European Heart Journal Supplements. 24
Background Due to the total lockdown during COVID–19 pandemic, clinicians were forced to organize telephone visits or tele–monitoring. We developed a standardized multiparametric questionnaire, suitable for telephone administration to older heart
Autor:
V Camartini, F Orso, A Herbst, S Virciglio, C Salucci, F Verga, G D‘Errico, M Di Bari, A Ungar, F Fattirolli, N Marchionni, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 24
Background The use of intermittent infusion of Levosimendan (L) demonstrated to be able to reduce hospitalisations and to improve functional capacity and quality of life in patients with advanced heart failure (HF). Purpose To describe our preliminar
Autor:
F Verga, F Orso, A Herbst, V Camartini, S Virciglio, G D‘Errico, C Salucci, M Di Bari, N Marchionni, A Ungar, F Fattirolli, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 24
Introduction The Coronavirus Disease (COVID–19) pandemic and its consequences has forced physicians to develop telematic methods in order to follow up patients with cronic diseases, such as heart failure (HF). Objectives To evaluate TeleHFCovid–1
Autor:
A Herbst, F Orso, V Camartini, S Virciglio, G D‘Errico, C Salucci, F Verga, F Fattirolli, N Marchionni, M Di Bari, A Ungar, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 24
Background Although older patients with heart failure (HF) with reduced ejection fraction enrolled in PARADIGM–HF showed a good tolerance to sacubitril/valsartan (Sa/Va), more real–word data are needed to define their tolerability in this populat
Autor:
S Virciglio, F Orso, A Herbst, V Camartini, E Girardi, C Ghiara, G Perfetti, A Pratesi, M Di Bari, A Ungar, F Fattirolli, N Marchionni, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 24
Background A multidisciplinary heart team and continuum care approach seems to be the most appropriate clinical strategy in order to reduce mortality, functional decline and disability of frail and clinical complex oldest old patients affected by hea
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.